azetidyl-2-carboxylic acid has been researched along with Kidney Failure, Chronic in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ishida, A; Ito, O; Kanazawa, M; Kohzuki, M; Kurosawa, H; Lu, H; Ootaka, T; Sasaki, Y; Sato, T; Tufescu, A | 1 |
Abe, K; Kanazawa, M; Kohzuki, M; Kurosawa, H; Minami, N; Saito, T; Yasujima, M; Yoshida, K | 1 |
Inoue, T; Kawagoe, Y; Koide, H; Nakamura, T; Node, K; Sugaya, T; Suzuki, T; Ueda, Y | 1 |
1 trial(s) available for azetidyl-2-carboxylic acid and Kidney Failure, Chronic
Article | Year |
---|---|
Azelnidipine reduces urinary protein excretion and urinary liver-type fatty acid binding protein in patients with hypertensive chronic kidney disease.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Adult; Amlodipine; Antioxidants; Azetidinecarboxylic Acid; Blood Pressure; Calcium Channel Blockers; Deoxyguanosine; Dihydropyridines; Fatty Acid-Binding Proteins; Female; Heart Rate; Humans; Hypertension; Kidney Failure, Chronic; Male; Middle Aged; Proteinuria | 2007 |
2 other study(ies) available for azetidyl-2-carboxylic acid and Kidney Failure, Chronic
Article | Year |
---|---|
Combination of chronic exercise and antihypertensive therapy enhances renoprotective effects in rats with renal ablation.
Topics: Ablation Techniques; Actins; Animals; Antihypertensive Agents; Azetidinecarboxylic Acid; Blood Urea Nitrogen; Combined Modality Therapy; Creatinine; Dihydropyridines; Exercise Therapy; Imidazoles; Kidney; Kidney Failure, Chronic; Male; Proteinuria; Rats; Rats, Inbred WKY; Tetrazoles | 2009 |
Combination therapy with an angiotensin-converting enzyme (ACE) inhibitor and a calcium antagonist: beyond the renoprotective effects of ACE inhibitor monotherapy in a spontaneous hypertensive rat with renal ablation.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Azetidinecarboxylic Acid; Calcium Channel Blockers; Dihydropyridines; Drug Therapy, Combination; Hypertension; Kidney; Kidney Failure, Chronic; Male; Nephrectomy; Protective Agents; Rats; Rats, Inbred SHR; Thiazepines | 2002 |